FRUMIL furosemide (frusemide) 40 mg and amiloride hydrochloride dihydrate 5 mg tablets

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

furosemide, Quantity: 40 mg; amiloride hydrochloride dihydrate, Quantity: 5 mg

Disponible depuis:

Sanofi-Aventis Australia Pty Ltd

DCI (Dénomination commune internationale):

amiloride hydrochloride dihydrate,furosemide (frusemide)

forme pharmaceutique:

Tablet, uncoated

Composition:

Excipient Ingredients: microcrystalline cellulose; sodium starch glycollate type A; maize starch; sunset yellow FCF; colloidal anhydrous silica; magnesium stearate; lactose monohydrate; purified talc

Mode d'administration:

Oral

Unités en paquet:

28

Type d'ordonnance:

(S1) This Schedule is intentionally blank

indications thérapeutiques:

FRUMIL is indicated for the treatment of cardiac failure, in patients who require diuretics plus potassium supplements, or potassium sparing diuretics.

Descriptif du produit:

Visual Identification: Orange tablets with breakline; FRUMIL on reverse side.; Container Type: Blister Pack; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

Statut de autorisation:

Licence status A

Date de l'autorisation:

2007-08-20